G
Guardant Health
Biotech & Life Sciences · Palo Alto, United States · Founded 2012 · IPO 2018
Guardant Health mafia
Startups founded by Guardant Health alumni
Former Guardant Health employees who went on to start their own companies. Sorted by Dealroom signal score.
Warren HogarthUnited States
Mark JacobsteinUnited States
Rajan Jethwa Ma MrcsUnited Kingdom
Diana AbduevaUnited States
Daniel DelubacUnited States
Dietrich StephanUnited States
Greg SchaferUnited StatesGlobal footprint
Where Guardant Health has talent and traffic
across markets
Talent graph
The shape of Guardant Health's talent
Dealroom maps Guardant Health's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$105M patent portfolio · 175 active families
Where Guardant Health concentrates vs peers
Each axis is a top-10 topic across Guardant Health and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Guardant Health's 2 investments and acquisitions.
Every disclosed deal where Guardant Health appeared as a backer or acquirer, 2021–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
2 deals across Guardant Health's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Guardant Health deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Guardant Health's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Guardant Health
An AI-synthesized read of the highest-engagement posts about Guardant Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Guardant Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.














